Supplementary Information for article: Quantification of EGFR/HER2 heterodimers in HER2-overexpressig breast cancer cells using liquid phase electron microscopy Contents: Figures S1-S4 Table S1 Supplementary Results Supplementary Methods Supplementary Reference
PurposeTargeting of the HER2 protein in human breast cancer represents a major advance in oncology b...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: Optimization of workflow for breast cancer samples with equivocal human epidermal growth...
Supplementary Information for article: Quantification of EGFR/HER2 heterodimers in HER2-overexpressi...
Currently, breast cancer patients are classified uniquely according to the expression level of hormo...
The development of drug resistance in cancer poses a major clinical problem. An example is human epi...
PURPOSE: Targeting of the HER2 protein in human breast cancer represents a major advance in oncology...
The human epidermal growth factor receptor-2 (HER2) protein has been associated with breast cancer p...
Definition of HER2-amplified breast cancer. (A) HER2 overexpression in 864 TCGA tumors is defined as...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
One in nine women in Canada will develop breast cancer during their lifetime. Generally, breast canc...
The epidermal growth factor receptor HER2 is overexpressed in 20% of breast cancer cases. HER2 is a...
<strong><em>Objective:</em></strong> Estrogen treatment limits the cytotoxic effects of chemotherapy...
Tissue microarray patient sample details. Table provides the details of reagents used in the study. ...
Figure S2. Flow cytometric detection of cell surface EGFR/HER2/HER3 expression after treatment with ...
PurposeTargeting of the HER2 protein in human breast cancer represents a major advance in oncology b...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: Optimization of workflow for breast cancer samples with equivocal human epidermal growth...
Supplementary Information for article: Quantification of EGFR/HER2 heterodimers in HER2-overexpressi...
Currently, breast cancer patients are classified uniquely according to the expression level of hormo...
The development of drug resistance in cancer poses a major clinical problem. An example is human epi...
PURPOSE: Targeting of the HER2 protein in human breast cancer represents a major advance in oncology...
The human epidermal growth factor receptor-2 (HER2) protein has been associated with breast cancer p...
Definition of HER2-amplified breast cancer. (A) HER2 overexpression in 864 TCGA tumors is defined as...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
One in nine women in Canada will develop breast cancer during their lifetime. Generally, breast canc...
The epidermal growth factor receptor HER2 is overexpressed in 20% of breast cancer cases. HER2 is a...
<strong><em>Objective:</em></strong> Estrogen treatment limits the cytotoxic effects of chemotherapy...
Tissue microarray patient sample details. Table provides the details of reagents used in the study. ...
Figure S2. Flow cytometric detection of cell surface EGFR/HER2/HER3 expression after treatment with ...
PurposeTargeting of the HER2 protein in human breast cancer represents a major advance in oncology b...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: Optimization of workflow for breast cancer samples with equivocal human epidermal growth...
DOI
Add to ORKG